CN EN

... Core Business ... Technology Application

Core Business

Cell Storage Technology Application Cosmetic wrinkle removal Drug R&D

Application

Cell Application

Cansbio NK Cell Immunotechnology

Immune technology based on natural killer cells (NK cells) includes two core solutions:

NKM Cell Technology

Technology SourceIntroduced technology from Odaka Hospital (Japan), integrating innate NK cells and adaptive T cells to synergistically enhance immune response.

Through mixed immune cell populations (NK+T), it strengthens the foundation of innate immunity while activating specific immune memory to form a long-term anti-cancer defense line.

Immune synergy effect of 1+1>2, breaking through the limitations of single therapy.
Improve sub-health, enhance immunity and resist aging.

Technical Highlights

NK-PLUS Cell Technology

Patented TechnologyJointly developed with the National Institutes of Health (NIH, US), adopting an iterative medium process to achieve high-purity and high-activity expansion of NK cells.

Application ScenariosFor viral infections and adjuvant tumor treatment; a single transfusion can significantly improve the targeted cytotoxicity of the immune system.

Technical Highlights

Patented culture system, producing high-purity, high-activity and clinical-grade NK cells.
On the basis of improving sub-health, it is used for anti-virus and adjuvant tumor treatment.

  • Address
    Unit 2, Building 11, Courtyard 20, Kechuang 14th Street, Beijing Economic and Technological Development Zone

  • Tel
    010-52936373

  • Interested candidates can send their resumes to
    mzeng@cansbio.com or contact us by phone: 010-52936373

Copyright © 2025 康思葆（北京）生物技术有限公司. All Rights Reserved备案号：京ICP备2020041676号-1京公网安备 11030102011019号